-
1دورية أكاديمية
المساهمون: Department of Surgery, Helsingborg Hospital, 25187 Helsingborg, Sweden.
مصطلحات موضوعية: Bris, Lyfjameðferð, Pancreatitis/chemically induced, Pancreatitis/complications, Loperamide/therapeutic use
الوصف: To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files. This article is open access. ; Acute pancreatitis is a common disease leading to hospitalizations, most often caused by gallstones or alcohol. We present a case of a patient diagnosed with acute pancreatitis considered to be due to loperamide treatment for diarrhea.
العلاقة: http://dx.doi.org/10.1155/2013/517414Test; Case Rep Gastrointest Med. 2013, 2013:517414; http://hdl.handle.net/2336/333726Test; Case reports in gastrointestinal medicine
-
2دورية أكاديمية
المؤلفون: Gunnarsdottir, Anna Ingibjorg, Gudjonsson, Hallgrimur, Hardardottir, Hjordis, Jonsdottir, Karen Drofn, Bjornsson, Einar Stefan
المساهمون: 1 Natl Univ Hosp Iceland, Landspitali, Hosp Pharm, Reykjavik, Iceland Show the Organization-Enhanced name(s) 2 Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland Show the Organization-Enhanced name(s) 3 Natl Univ Hosp Iceland, Landspitali, Dept Internal Med, Reykjavik, Iceland Show the Organization-Enhanced name(s) 4 Univ Iceland, Fac Med, Reykjavik, Iceland Show the Organization-Enhanced name(s) 5 Natl Univ Hosp Iceland, Landspitali, Dept Clin Microbiol, Reykjavik, Iceland
مصطلحات موضوعية: Bakteríusjúkdómar, Lyfjameðferð, Magasár, GAS12, LYF12, BAC12, Helicobacter pylori, Drug Resistance, Bacterial
الوصف: To access publisher's full text version of this article click on the hyperlink below ; Increasing resistance of Helicobacter pylori (H. pylori) to antibiotics calls for constant re-evaluation of multidrug regimens that have been used to eradicate the infection. The aim of this study was to evaluate the current antibiotic susceptibility of H. pylori in an Icelandic cohort. ; Patients referred for gastroscopy were recruited prospectively. Those found to have a positive rapid urease test were included in the study. Susceptibility testing was conducted by the Epsilometer test (E-test) method for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline. Results were obtained after three days of incubation in microaerophilic conditions at 37 °C, except for the metronidazole were the first 24 hours were anaerobic. ; Of the 613 patients who underwent gastroscopy, 138 (23%) had a positive rapid urease test. H. pylori was successfully cultured from 105 (76%) of the urease test positive patients and the isolates were tested for antibiotic susceptibility. Five patients had prior H. pylori eradication. Antibiotic resistance for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline was 0%, 9%, 4%, 1% and 0%, respectively. If those who had previously undergone eradication treatment were excluded, the resistance was 0%, 6%, 3%, 1% and 0%, respectively. Clarithromycin resistance was higher amongst women than men, 13% vs. 5%, however, not significantly. Clarithromycin resistance was 60% amongst those who had previously received eradication treatment compared to 6% of those who had not (p < .0001). ; Clarithromycin resistance amongst the H. pylori isolates can be considered relatively low. Therefore, in the current cohort, standard triple-drug clarithromycin-containing regimen should remain the first-line treatment against H. pylori. ; Actavis Group ptc Landspitali University Hospital of Iceland
العلاقة: Antibiotic susceptibility of Helicobacter pylori in Iceland. 2017, 49 (9):647-654 Infect Dis (Lond); http://hdl.handle.net/2336/620275Test; Infectious diseases (London, England)
-
3دورية أكاديمية
المؤلفون: Gunnarsdottir, Anna Ingibjorg, Gudjonsson, Hallgrimur, Hardardottir, Hjordis, Jonsdottir, Karen Drofn, Bjornsson, Einar Stefan
المساهمون: 1 Natl Univ Hosp Iceland, Landspitali, Hosp Pharm, Reykjavik, Iceland Show the Organization-Enhanced name(s) 2 Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland Show the Organization-Enhanced name(s) 3 Natl Univ Hosp Iceland, Landspitali, Dept Internal Med, Reykjavik, Iceland Show the Organization-Enhanced name(s) 4 Univ Iceland, Fac Med, Reykjavik, Iceland Show the Organization-Enhanced name(s) 5 Natl Univ Hosp Iceland, Landspitali, Dept Clin Microbiol, Reykjavik, Iceland
مصطلحات موضوعية: Bakteríusjúkdómar, Lyfjameðferð, Magasár, GAS12, LYF12, BAC12, Helicobacter pylori, Drug Resistance, Bacterial, socio
الوصف: To access publisher's full text version of this article click on the hyperlink below ; Increasing resistance of Helicobacter pylori (H. pylori) to antibiotics calls for constant re-evaluation of multidrug regimens that have been used to eradicate the infection. The aim of this study was to evaluate the current antibiotic susceptibility of H. pylori in an Icelandic cohort. ; Patients referred for gastroscopy were recruited prospectively. Those found to have a positive rapid urease test were included in the study. Susceptibility testing was conducted by the Epsilometer test (E-test) method for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline. Results were obtained after three days of incubation in microaerophilic conditions at 37 °C, except for the metronidazole were the first 24 hours were anaerobic. ; Of the 613 patients who underwent gastroscopy, 138 (23%) had a positive rapid urease test. H. pylori was successfully cultured from 105 (76%) of the urease test positive patients and the isolates were tested for antibiotic susceptibility. Five patients had prior H. pylori eradication. Antibiotic resistance for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline was 0%, 9%, 4%, 1% and 0%, respectively. If those who had previously undergone eradication treatment were excluded, the resistance was 0%, 6%, 3%, 1% and 0%, respectively. Clarithromycin resistance was higher amongst women than men, 13% vs. 5%, however, not significantly. Clarithromycin resistance was 60% amongst those who had previously received eradication treatment compared to 6% of those who had not (p < .0001). ; Clarithromycin resistance amongst the H. pylori isolates can be considered relatively low. Therefore, in the current cohort, standard triple-drug clarithromycin-containing regimen should remain the first-line treatment against H. pylori. ; Actavis Group ptc Landspitali University Hospital of Iceland
النص الكامل